HZNP logo

Horizon Therapeutics Public Limited (HZNP) Free Cash Flow

Annual FCF

$1.13 B
+$224.46 M+24.75%

31 December 2022

HZNP Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly FCF

$143.00 M
+$95.81 M+203.00%

30 June 2023

HZNP Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM FCF

$906.13 M
-$96.04 M-9.58%

30 June 2023

HZNP TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HZNP Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+218.0%-57.6%+23.5%
5 y5 years+536.5%+72.2%+175.9%

HZNP Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall timeat high-72.3%-28.6%

Horizon Therapeutics Public Limited Free Cash Flow History

DateAnnualQuarterlyTTM
June 2023
-
$143.00 M(+203.0%)
$906.13 M(-9.6%)
Mar 2023
-
$47.20 M(-87.6%)
$1.00 B(-11.4%)
Dec 2022
$1.13 B(+24.7%)
$379.28 M(+12.7%)
$1.13 B(-10.8%)
Sept 2022
-
$336.65 M(+40.8%)
$1.27 B(-0.0%)
June 2022
-
$239.04 M(+35.4%)
$1.27 B(+14.8%)
Mar 2022
-
$176.59 M(-65.8%)
$1.11 B(+21.9%)
Dec 2021
$907.10 M(+154.9%)
$516.58 M(+53.2%)
$907.10 M(+23.6%)
Sept 2021
-
$337.10 M(+346.6%)
$733.88 M(+49.1%)
June 2021
-
$75.48 M(-442.1%)
$492.22 M(-4.5%)
Mar 2021
-
-$22.06 M(-106.4%)
$515.37 M(+44.8%)
Dec 2020
$355.84 M(-12.9%)
$343.36 M(+259.8%)
$355.84 M(+80.3%)
Sept 2020
-
$95.43 M(-3.2%)
$197.32 M(+6.7%)
June 2020
-
$98.64 M(-154.3%)
$184.94 M(+7.2%)
Mar 2020
-
-$181.60 M(-198.2%)
$172.56 M(-57.8%)
Dec 2019
$408.48 M(+129.8%)
$184.85 M(+122.6%)
$408.48 M(+24.4%)
Sept 2019
-
$83.05 M(-3.7%)
$328.44 M(-0.5%)
June 2019
-
$86.26 M(+58.8%)
$330.14 M(+8.0%)
Mar 2019
-
$54.32 M(-48.2%)
$305.57 M(+71.9%)
Dec 2018
$177.77 M(-36.5%)
$104.82 M(+23.7%)
$177.77 M(-17.7%)
Sept 2018
-
$84.74 M(+37.4%)
$215.91 M(+9.0%)
June 2018
-
$61.69 M(-184.0%)
$198.11 M(+8.2%)
Mar 2018
-
-$73.48 M(-151.4%)
$183.15 M(-34.6%)
Dec 2017
$280.00 M(-20.8%)
$142.95 M(+113.5%)
$280.00 M(+1.8%)
Sept 2017
-
$66.95 M(+43.3%)
$275.13 M(-17.9%)
June 2017
-
$46.72 M(+99.8%)
$335.13 M(+1.4%)
Mar 2017
-
$23.38 M(-83.1%)
$330.46 M(-6.6%)
Dec 2016
$353.73 M
$138.08 M(+8.8%)
$353.73 M(+1.7%)
Sept 2016
-
$126.95 M(+201.9%)
$347.95 M(+13.3%)
June 2016
-
$42.05 M(-9.9%)
$307.15 M(+0.4%)
DateAnnualQuarterlyTTM
Mar 2016
-
$46.66 M(-64.7%)
$305.98 M(+63.6%)
Dec 2015
$187.01 M(+677.6%)
$132.30 M(+53.6%)
$187.01 M(+196.2%)
Sept 2015
-
$86.15 M(+110.7%)
$63.13 M(-382.4%)
June 2015
-
$40.88 M(-156.5%)
-$22.35 M(-52.5%)
Mar 2015
-
-$72.32 M(-959.3%)
-$47.02 M(-295.5%)
Dec 2014
$24.05 M(-143.3%)
$8.42 M(+1163.7%)
$24.05 M(+516.6%)
Sept 2014
-
$666.00 K(-95.9%)
$3.90 M(-160.0%)
June 2014
-
$16.22 M(-1396.4%)
-$6.50 M(-80.7%)
Mar 2014
-
-$1.25 M(-89.3%)
-$33.74 M(-39.2%)
Dec 2013
-$55.48 M(-28.8%)
-$11.73 M(+20.5%)
-$55.48 M(-9.4%)
Sept 2013
-
-$9.74 M(-11.6%)
-$61.24 M(-17.6%)
June 2013
-
-$11.02 M(-52.1%)
-$74.30 M(-7.2%)
Mar 2013
-
-$22.99 M(+31.5%)
-$80.05 M(+2.7%)
Dec 2012
-$77.98 M(+80.7%)
-$17.49 M(-23.3%)
-$77.98 M(+2.3%)
Sept 2012
-
-$22.80 M(+36.0%)
-$76.24 M(+8.7%)
June 2012
-
-$16.77 M(-19.9%)
-$70.15 M(+21.9%)
Mar 2012
-
-$20.92 M(+32.8%)
-$57.53 M(+33.3%)
Dec 2011
-$43.14 M(+12.8%)
-$15.76 M(-5.7%)
-$43.14 M(+21.0%)
Sept 2011
-
-$16.71 M(+303.2%)
-$35.67 M(+16.9%)
June 2011
-
-$4.14 M(-36.6%)
-$30.50 M(-23.8%)
Mar 2011
-
-$6.54 M(-21.0%)
-$40.01 M(+4.6%)
Dec 2010
-$38.25 M(+101.2%)
-$8.28 M(-28.2%)
-$38.25 M(+10.2%)
Sept 2010
-
-$11.54 M(-15.5%)
-$34.69 M(+26.1%)
June 2010
-
-$13.65 M(+185.9%)
-$27.52 M(+48.8%)
Mar 2010
-
-$4.78 M(+1.1%)
-$18.49 M(-2.7%)
Dec 2009
-$19.01 M(-23.2%)
-$4.72 M(+8.3%)
-$19.01 M(+33.1%)
Sept 2009
-
-$4.36 M(-5.7%)
-$14.29 M(+43.9%)
June 2009
-
-$4.63 M(-12.6%)
-$9.92 M(+87.4%)
Mar 2009
-
-$5.30 M
-$5.30 M
Dec 2008
-$24.76 M
-
-

FAQ

  • What is Horizon Therapeutics Public Limited annual free cash flow?
  • What is the all time high annual FCF for Horizon Therapeutics Public Limited?
  • What is Horizon Therapeutics Public Limited quarterly free cash flow?
  • What is the all time high quarterly FCF for Horizon Therapeutics Public Limited?
  • What is Horizon Therapeutics Public Limited TTM free cash flow?
  • What is the all time high TTM FCF for Horizon Therapeutics Public Limited?

What is Horizon Therapeutics Public Limited annual free cash flow?

The current annual FCF of HZNP is $1.13 B

What is the all time high annual FCF for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high annual free cash flow is $1.13 B

What is Horizon Therapeutics Public Limited quarterly free cash flow?

The current quarterly FCF of HZNP is $143.00 M

What is the all time high quarterly FCF for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high quarterly free cash flow is $516.58 M

What is Horizon Therapeutics Public Limited TTM free cash flow?

The current TTM FCF of HZNP is $906.13 M

What is the all time high TTM FCF for Horizon Therapeutics Public Limited?

Horizon Therapeutics Public Limited all-time high TTM free cash flow is $1.27 B